A Multicenter Randomized, Double-Blind, Placebo-controlled, Dosing, Safety and Efficacy Study of IMM 124-E (Hyperimmune Bovine Colostrum) for Patients With Severe Alcoholic Hepatitis
Phase: PHASE2
Conditions: Hepatitis, Alcoholic
Sponsor: Virginia Commonwealth University

 
 
Title: A Multicenter Randomized, Double-Blind, Placebo-controlled, Dosing, Safety, and Efficary Study of 
IMM 124-E (Hyperimmune Bovine Colostrum) for Patients with Severe Alcoholic Hepatitis. 
 
NCT #: NCT01968382 
 
Document approval date: August 15, 2016 
 
Document Type: Full study protocol and statistical analysis plan